CombiSep Appoints ProGroup Instrument As Central USA Distributor
News Nov 04, 2005
“ProGroup has a strong reputation as a supplier to the life science industry,” says Mark McDonald, CombiSep s Chief Operating Officer.
He adds “This agreement will assist CombiSep in providing separation solutions to pharmaceutical and other biotechnology customers in the central states.”
“We are very excited about bringing CombiSep s unique technology to our customers. CombiSep s instruments, consumables and software complement our life science solutions portfolio.”
“Our experience with plate and liquid handlers, and ProGroup s reputation as a supplier of quality products, will facilitate access to the client base for CombiSep s products,” states Scott Hovey, President of ProGroup.
CombiSep's cePRO 9600 is designed to allow researchers to analyze up to 96 samples in parallel. Applications for biomolecules include: protein analysis, DNA sizing, amino acid analysis and oligonucleotide purity determination.
Other applications include high-throughput screening and separation of small molecules.
Reagent kits are available for performing pKa and log P analyses, protein sizing, dsDNA sizing, and oligonucleotide purity analysis.
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.